About genscript biotech corp - GNNSF
Genscript Biotech Corp. operates as a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Life-science Services and Products, Biologics Development Services, and Industrial Synthetic Biology Products. The Life-science Services and Products segment provides research services and products used for life-science research and application. The Biologics Development Services segment focuses on services aimed to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and CGT products with an integrated platform. The Industrial Synthetic Biology Products segment comprises of industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Hong Kong.
GNNSF At a Glance
Genscript Biotech Corp.
40th Floor
Hong Kong,
| Phone | N/A | Revenue | 959.53M | |
| Industry | Biotechnology | Net Income | -532,830,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 60.147% | |
| Fiscal Year-end | 12 / 2026 | Employees | 6,165 | |
| View SEC Filings |
GNNSF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 3.604 |
| Price to Book Ratio | 0.871 |
| Price to Cash Flow Ratio | 10.28 |
| Enterprise Value to EBITDA | 9.808 |
| Enterprise Value to Sales | 3.366 |
| Total Debt to Enterprise Value | 0.189 |
GNNSF Efficiency
| Revenue/Employee | 155,640.876 |
| Income Per Employee | -86,428.224 |
| Receivables Turnover | 6.034 |
| Total Asset Turnover | 0.189 |
GNNSF Liquidity
| Current Ratio | 1.468 |
| Quick Ratio | 1.413 |
| Cash Ratio | 1.171 |
GNNSF Profitability
| Gross Margin | 57.654 |
| Operating Margin | 26.601 |
| Pretax Margin | -15.649 |
| Net Margin | -55.531 |
| Return on Assets | -10.518 |
| Return on Equity | -12.87 |
| Return on Total Capital | -11.663 |
| Return on Invested Capital | -12.543 |
GNNSF Capital Structure
| Total Debt to Total Equity | 15.385 |
| Total Debt to Total Capital | 13.334 |
| Total Debt to Total Assets | 12.551 |
| Long-Term Debt to Equity | 3.56 |
| Long-Term Debt to Total Capital | 3.085 |